Aura Biosciences, Inc. (AURA) Financials
AURA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 179.8 million | 28.0 million |
2023-06-30 | 192.7 million | 26.3 million |
2023-03-31 | 206.0 million | 25.8 million |
2022-12-31 | 223.9 million | 28.4 million |
AURA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -15.5 million | 2.3 million |
2023-06-30 | -14.8 million | 1.9 million |
2023-03-31 | -16.5 million | 1.9 million |
2022-12-31 | -18.4 million | 1.8 million |
AURA Net Income
No data available :(
AURA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 149.1 million | - | 20.2 million |
2023-06-30 | 162.0 million | - | 20.4 million |
2023-03-31 | 173.5 million | - | 20.6 million |
2022-12-31 | 188.8 million | - | 20.9 million |
AURA Shares Outstanding
AURA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 90000 | 15.4 million | 5.1 million | - |
2023-06-30 | 193000 | 15.1 million | 5.2 million | - |
2023-03-31 | 109000 | 14.4 million | 5.0 million | - |
2022-12-31 | 358000 | 13.2 million | 4.5 million | - |
AURA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 400000 |
2023-06-30 | - | 300000 |
2023-03-31 | - | 328000 |
2022-12-31 | - | 323000 |
AURA
Price: $7.89
52 week price:
Earnings Per Share: -1.95 USD
P/E Ratio: -4.10
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 120900
Market Capitalization: 380.0 million